The fully linked HTML version of this article has now been published.
JCS ePress
online publication date 1 Sep 2005
doi: 10.1242/jcs.02546
Research Article
Antiandrogens prevent stable DNA-binding of the androgen receptor
Pascal Farla,
Remko Hersmus,
Jan Trapman,
and
Adriaan B. Houtsmuller*
* Author for correspondence (e-mail: a.houtsmuller{at}erasmusmc.nl)
The androgen receptor (AR) is essential for development of the male gender and in the growth of the majority of prostate cancers. Agonists as well as most antagonists induce translocation of the receptor to the nucleus, whereas only agonists can activate AR function. Antagonists are therefore used in the therapy of metastasized prostate cancer. To obtain insight into the mechanism by which antagonists block AR function in living cells, we studied nuclear mobility and localization of green fluorescent protein (GFP)-tagged AR in the presence of either the agonist R1881 or the antagonists bicalutamide and hydroxyflutamide. As controls we investigated a non-DNA-binding AR mutant (A573D) and two mutants (W741C and T877A) with broadened ligand specificity. We demonstrate that in the presence of R1881, AR localizes in numerous intranuclear foci and, using complementary fluorescence recovery after photobleaching (FRAP) approaches and computer modelling, that a fraction of AR (
10-15%) is transiently immobilized in a DNA-binding-dependent manner (individual ARs being immobile for 45 seconds). By contrast, antagonist-bound GFP-AR showed no detectable immobile fraction and the mobility was similar to that of the R1881-liganded non-DNA-binding mutant (A573D), indicating that antagonists do not induce the relatively stable DNA-binding-dependent immobilization observed with agonist-bound AR. Moreover, in the presence of bicalutamide and hydroxyflutamide GFP-AR was homogeneously distributed in the nucleus. Binding of bicalutamide and hydroxyflutamide to GFP-AR(W741C) and GFP-AR(T877A), respectively, resulted in similar mobility and heterogeneous nuclear distribution as observed for R1881-liganded GFP-AR. The live cell studies indicate that the investigated antagonists interfere with events early in the transactivation function of the AR.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
K. De Gendt, C. McKinnell, A. Willems, P. T.K. Saunders, R. M. Sharpe, N. Atanassova, J. V. Swinnen, and G. Verhoeven
Organotypic Cultures of Prepubertal Mouse Testes: A Method to Study Androgen Action in Sertoli Cells while Preserving their Natural Environment
Biol Reprod,
December 1, 2009;
81(6):
1083 - 1092.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Lenie and J. Smitz
Functional AR Signaling Is Evident in an In Vitro Mouse Follicle Culture Bioassay That Encompasses Most Stages of Folliculogenesis
Biol Reprod,
April 1, 2009;
80(4):
685 - 695.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. A. Johnson, C. Elbi, B. S. Parekh, G. L. Hager, and S. John
Chromatin Remodeling Complexes Interact Dynamically with a Glucocorticoid Receptor-regulated Promoter
Mol. Biol. Cell,
August 1, 2008;
19(8):
3308 - 3322.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. C. Shank, J. B. Kelley, D. Gioeli, C.-S. Yang, A. Spencer, L. A. Allison, and B. M. Paschal
Activation of the DNA-dependent Protein Kinase Stimulates Nuclear Export of the Androgen Receptor in Vitro
J. Biol. Chem.,
April 18, 2008;
283(16):
10568 - 10580.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. H. Bisson, A. V. Cheltsov, N. Bruey-Sedano, B. Lin, J. Chen, N. Goldberger, L. T. May, A. Christopoulos, J. T. Dalton, P. M. Sexton, et al.
Discovery of antiandrogen activity of nonsteroidal scaffolds of marketed drugs
PNAS,
July 17, 2007;
104(29):
11927 - 11932.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Nakauchi, K.-i. Matsuda, I. Ochiai, A. Kawauchi, Y. Mizutani, T. Miki, and M. Kawata
A Differential Ligand-mediated Response of Green Fluorescent Protein-tagged Androgen Receptor in Living Prostate Cancer and Non-prostate Cancer Cell Lines
J. Histochem. Cytochem.,
June 1, 2007;
55(6):
535 - 544.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. E. van Royen, S. M. Cunha, M. C. Brink, K. A. Mattern, A. L. Nigg, H. J. Dubbink, P. J. Verschure, J. Trapman, and A. B. Houtsmuller
Compartmentalization of androgen receptor protein-protein interactions in living cells
J. Cell Biol.,
April 9, 2007;
177(1):
63 - 72.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. I. Klokk, P. Kurys, C. Elbi, A. K. Nagaich, A. Hendarwanto, T. Slagsvold, C.-Y. Chang, G. L. Hager, and F. Saatcioglu
Ligand-Specific Dynamics of the Androgen Receptor at Its Response Element in Living Cells
Mol. Cell. Biol.,
March 1, 2007;
27(5):
1823 - 1843.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Tudor, J. N. Feige, H. Pingali, V. B. Lohray, W. Wahli, B. Desvergne, Y. Engelborghs, and L. Gelman
Association with Coregulators Is the Major Determinant Governing Peroxisome Proliferator-activated Receptor Mobility in Living Cells
J. Biol. Chem.,
February 16, 2007;
282(7):
4417 - 4426.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y.-C. Chuan, S.-T. Pang, A. Cedazo-Minguez, G. Norstedt, A. Pousette, and A. Flores-Morales
Androgen Induction of Prostate Cancer Cell Invasion Is Mediated by Ezrin
J. Biol. Chem.,
October 6, 2006;
281(40):
29938 - 29948.
[Abstract]
[Full Text]
[PDF]
|
|
|
© The Company of Biologists Ltd 2005
